Posted by Michael Wonder on 25 Jan 2023
UK to introduce first of its kind framework to make it easier to manufacture innovative medicines at the point of care
25 January 2023 - The establishment of a regulatory framework for point of care manufacturing would bring a range of benefits to patients, health care professionals and innovators.
The UK will be the first country to introduce a tailored framework for the regulation of innovative products manufactured at the point where a patient receives care, the MHRA has announced today. This will mean that new medicines with very short shelf lives and highly personalised medicines can more easily be made in or near a hospital setting or ambulance and can get to the patients who need them much more quickly.
